These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32158230)

  • 1. Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m
    Wang K; Jiang L; Zhang Y; Chen C
    Onco Targets Ther; 2020; 13():1605-1612. PubMed ID: 32158230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.
    Yu X; Zhao H; Cao Z
    Minerva Med; 2022 Apr; 113(2):309-314. PubMed ID: 32512975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
    Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
    J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
    Cheng Y; Fu Y; Wang Y; Wang J
    Front Genet; 2020; 11():955. PubMed ID: 33061938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
    Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
    Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyltransferase-like 3 Aggravates HCC Development via Mediating N6-Methyladenosine of Ubiquitin-Specific Protease 7.
    Yuan D; Chen J; Hao Q; Zhang P; Chen Z
    J Oncol; 2022; 2022():6167832. PubMed ID: 35571490
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huang S; Chen B; Qiu P; Yan Z; Liang Z; Luo K; Huang B; Jiang H
    Transl Cancer Res; 2023 Jun; 12(6):1588-1601. PubMed ID: 37434681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
    Zhao C; Ling X; Xia Y; Yan B; Guan Q
    Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.
    Chen WW; Qi JW; Hang Y; Wu JX; Zhou XX; Chen JZ; Wang J; Wang HH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4263-4270. PubMed ID: 32373962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.